Skip to Main Content

Neil Dunavin

MD MS

Hematologist
Hiker, swimmer and research enthusiast

Dr. Neil Dunavin is a hematologist who cares for patients with leukemia, including those receiving stem cell transplantation. He also treats patients with myelodysplastic syndromes (bone marrow disorders that cause abnormalities in the blood cells produced there), myeloproliferative neoplasms (blood cancers that occur when the bone marrow overproduces one of the blood cell types), aplastic anemia (when the bone marrow stops making enough new blood cells) and bone marrow failure (when the body's needs for new healthy blood cells are not being met).

Dunavin's research focuses on treatments for blood and bone marrow cancers. He has been involved in numerous clinical trials to evaluate promising therapies. He is also interested in quality improvement for patient care in hematology and stem cell transplantation.

Dunavin earned his medical degree at the University of Kansas School of Medicine. He completed a residency in internal medicine at the Ohio State University Wexner Medical Center, where he served as chief resident. He completed a fellowship in hematology and stem cell transplantation at the National Institutes of Health Clinical Center. He also has a master's degree in clinical research from the Duke University School of Medicine.

Dunavin has lectured and published extensively in the field of hematology. He is a member of the American Society of Hematology, American Society for Transplantation and Cellular Therapy, International Society for Cellular Therapy and American Society of Gene & Cell Therapy.

Dunavin is passionate about providing health care through volunteer clinics, both domestically and abroad. He has participated in medical outreach to two countries in East Africa and works with hematology trainees at Muhimbili National Hospital in Dar es Salaam, Tanzania.

  • Education

    University of Kansas School of Medicine, MD, 2009

  • Residencies

    Ohio State University, Internal Medicine, 2012

  • Fellowships

    National Institutes of Health, Hematology, 2015

  • Academic Title

    Assistant Professor

It is an honor to be a part of a wonderful team that is wholly committed to providing excellent care for patients with blood diseases and cancer.

Where I see patients (1)

    My reviews

    4.9

    Overall Experience
    144 Ratings
    About our process
    Nov 27, 2023
    He is clearly engaged in the conversation and answers all my questions. It has been 11/2 weeks and I have not heard back about scheduling future appointments or the labs being ordered.
    Nov 04, 2023
    Extremely thankful that my provider listened to all my questions and concerns and helped me put my mind to some ease.
    Oct 25, 2023
    Dr Neil Dunavin & his staff have been very respectful & professional during my visits.
    Oct 23, 2023
    I have been dealing with leukemia in one form or fashion since 2000. I have received treatment and consultations from world renowned physicians at the best research medical centers in the U.S. I have consulted with UCSF several times in the past ten years. Dr. Dunavin and UCSF rank at the top of the quality scale.
    Oct 10, 2023
    Dr Dunavin is great! I'm very happy with him as my Hematologist.
    Sep 18, 2023
    A very compassionate and caring doctor!
    Jul 20, 2023
    Everything was positive and we were treated well.
    Jul 05, 2023
    Very good experience!
    Jun 21, 2023
    Dr Dunavin is an excellent listener and communicator. My care is always tailored to me. I would recommend him wholeheartedly.
    May 17, 2023
    Dr Dunavin is a very nice and compassionate person. I'm very pleased with the care he offers.
    Apr 27, 2023
    Both Dr and NP very responsive.
    Apr 18, 2023
    My doctor of 25 years retired and Dr. Dunavin is my new doctor. We had a very good discussion concerning my issues. I felt he listened to all I had to say.
    Apr 13, 2023
    I really appreciate Dr. Dunavin as he LISTENS to me and then responds after taking a look at my labs if necessary. He Seems to be an excellent doctor for me!
    Apr 03, 2023
    Dr. Dunavin was very helpful and considerate.
    Mar 13, 2023
    My expectations were to get more info on the clinical trial but the visit was as he said "a meet and greet" session. A very expensive superficial (as far as information) meeting. And only 30 minutes. Was told it would be an hour give or take.Apparently a more thorough meeting will be next.
    Feb 19, 2023
    Dr. Dunavin and his staff are simply the best!
    Feb 10, 2023
    I feel Doctor is probably over extended with tasks!
    Dec 20, 2022
    Dr. Neil Dunavin has been an excellent health care provider. He is patient kind & gives excellent feedback. He answered all of my questions & was easy to converse with.
    Nov 25, 2022
    The care provider was better than I could ever have hoped for. Professional courteous very easy to talk to on a human level.
    Nov 25, 2022
    Dr. Dunavin is the best!
    Nov 20, 2022
    This is only the second time I've spoken with Dr Dunavin and was pleased our visit went well.
    Oct 06, 2022
    Dr. Dunavin is excellent at communicating and quite patient! I very much appreciate his "bedside manner" via telephone.
    Sep 13, 2022
    All excellent
    Jul 21, 2022
    Dr Dunavin seemed very interested in any questions or comments I had to make gave clear answers or opinions and his personal manner gave me a high comfort level.
    May 18, 2022
    Dr. Dunavin is great!
    May 06, 2022
    Will be having a bone marrow procedure in 2-3 months.
    Feb 10, 2022
    This was a one time consultation with Dr. Dunavin regarding a bone marrow transplant. I found him to be knowledgeable caring and patient a very good listener and an excellent explainer.
    Decorative Caduceus

    A Study of JNJ-75276617 in Participants With Acute Leukemia

    An AE is any untoward medical occurrence in a participant participating in a clinical study that does not necessarily have a causal relationship with the pharmaceutical/biological agent under study.

    Recruiting

    Share